The company partners with established compounding pharmacies including Belmar Pharma Solutions and Beluga Health
The feasibility of using the sybodies to purify TGP-fusion membrane proteins was demonstrated using ms SI-TGP expressed in E
Tissue was placed in transport media (DMEM containing L-glutamine, 10% FCS, 5 Pen/Strep, 3 antifungal) immediately after removal
Novel GLP-1 receptor agonists with enhanced efficacy and fewer side effects are in development, potentially broadening their application in OSA management
However, everyone reacts to GLP-1 therapy differently, and some may take a bit longer to reach the full dose
Moreover, their expression was positively correlated with that of fibronectin, an ECM protein